Switching from Efavirenz Does Not Improve Cognitive Function

Despite effective antiretroviral therapy (ART), mild cognitive impairment (things like decreased attention span, poorer memory, worse problem-solving ability) remains common in people living with HIV. The reasons for this are poorly understood and little is known about the impact of specific anti-HIV drugs on neurological function. However, efavirenz – one of the most commonly used antiretrovirals […]

Cognitive Impairment

Many people living with HIV (PLWH) are concerned by reports that mild cognitive impairment is more common, and occurs at a younger age, in people living with HIV than in other people. A new study from Holland gives us a clearer picture of this problem. Mild cognitive impairment can become evident in the form of changes […]

Study suggests HIV-positive gay men in UK do not have increased risk of neurocognitive impairment

Thanks to effective antiretroviral treatment, HIV-associated dementia is now rare. However, some research has suggested that as many as 50% of people living with HIV have some form of (usually mild) neurocognitive impairment, such as memory loss or mild confusion. Other studies, though, show no difference between the HIV positive and negative populations. To further […]

Traditional risk factors predict neurocognitive impairment in people with HIV

There is considerable interest in the frequency and causes of neurocognitive impairment – loss of memory, poor concentration and declining mental ability – in people with HIV. Some studies have suggested that the majority of people with HIV, even in the era of modern antiretroviral treatment, have some form of impairment. This detailed study, however, finds that neurocognitive impairment […]